Literature DB >> 27273076

Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.

Jessie Grewal1, Poorvi Dalal1, Michelle Bowman1,2, Behiye Kaya3, José Javier Otero3, Jaime Imitola4,5,6.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a viral demyelinating disease due to the reactivation of the JC virus (JCV), which usually occurs in the context of immunosuppression in HIV infection, malignancy, or in patients on disease modifying therapy for autoimmune diseases, such as multiple sclerosis (MS) and Crohn's disease. Notably, there is growing recognition that PML can occur in patients with transient immune dysfunction. Here, we present a case of a 55-year-old man without history of immunosuppression or evidence of ICL who was diagnosed with PML on brain biopsy. We will discuss the potential etiologies of mild and transient immunosuppression that can lead to PML with non-apparent immunosuppression.

Entities:  

Keywords:  Immunocompetent host; Progressive multifocal leukoencephalopathy

Mesh:

Year:  2016        PMID: 27273076     DOI: 10.1007/s13365-016-0459-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  22 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits.

Authors:  Igor J Koralnik; Dawid Schellingerhout; Matthew P Frosch
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 3.  Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

Authors:  Leonard H Calabrese; Eamonn S Molloy; DeRen Huang; Richard M Ransohoff
Journal:  Arthritis Rheum       Date:  2007-07

Review 4.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

5.  Primary progressive multifocal leukoencephalopathy. A case report.

Authors:  C F Bolton; B Rozdilsky
Journal:  Neurology       Date:  1971-01       Impact factor: 9.910

Review 6.  Idiopathic CD4 lymphocytopenia.

Authors:  Ulrich A Walker; Klaus Warnatz
Journal:  Curr Opin Rheumatol       Date:  2006-07       Impact factor: 5.006

Review 7.  Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).

Authors:  Jan Bauer; Ralf Gold; Ortwin Adams; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2015-09-01       Impact factor: 17.088

Review 8.  Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia.

Authors:  Manuel Delgado-Alvarado; María José Sedano; Vicente González-Quintanilla; Enrique Marco de Lucas; José Miguel Polo; José Berciano
Journal:  J Neurol Sci       Date:  2013-03-05       Impact factor: 3.181

9.  PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel.

Authors:  R Hess; J Oberbeck; T Grussenmeyer; A Schoeffel-Keller; C Haessler; D G Braun; G Brandner
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

10.  Progressive multifocal leukoencephalopathy in an immunocompetent patient?

Authors:  Krisztina K Johansen; Sverre H Torp; Jana Rydland; Jan O Aasly
Journal:  Case Rep Neurol       Date:  2013-09-04
View more
  5 in total

Review 1.  Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Authors:  Elena Grebenciucova; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

2.  Progressive multifocal leukoencephalopathy in the absence of immunosuppression.

Authors:  Benjamin E Zucker; Sybil R L Stacpoole
Journal:  J Neurovirol       Date:  2017-11-14       Impact factor: 2.643

3.  Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.

Authors:  Lea Krey; Peter Raab; Romilda Sherzay; Georg Berding; Matthias Stoll; Martin Stangel; Florian Wegner
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

4.  Rare but not beyond care: a young female with altered mental status and seizures.

Authors:  Samata Pathireddy; Subashish Bose; Krishna Baradhi; Narothama Reddy Aeddula
Journal:  Oxf Med Case Reports       Date:  2019-08-01

5.  A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors.

Authors:  Sinah Engel; Lara S Molina Galindo; Stefan Bittner; Frauke Zipp; Felix Luessi
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.